Jacky Rosen Stock Trades

Jacky Rosen Stock Trades: Senate Financial Disclosures

Nearly every one of Jacky Rosen's disclosed transactions is coded as an exchange, not a purchase or a sale. Across the 34 transactions disclosed since 2017, Quantellect's data shows zero purchases and only three sales. The remaining 31 fall into an "other" category and are identified as exchanges in the row-level data. Many explicitly name one security as exchanged and another as received, while others list only the security associated with the transaction. That pattern is the single most defining feature of the senator's disclosure record: the data primarily documents exchange activity rather than purchases or sales, without establishing the investment intent behind any transaction.

Attribution matters just as much as activity type. Of the 34 transactions, 14 are coded joint, 10 carry an unknown or unavailable attribution, 6 are attributed to Rosen herself, and 4 to a spouse. None are attributed to a dependent child. Joint transactions cannot be read as Rosen's individual decision-making, and the 10 unattributed entries cannot be assigned to her or a family member from the available source data. Only six of the disclosed transactions are explicitly attributed to Rosen herself.

What the exchanges actually show

The most recent activity on file involves General Electric. On January 3, 2023, an official filing shows General Electric Company common stock exchanged for shares of GE HealthCare Technologies Inc. The row-level data presents related entries under GE and combined GE/GEHC ticker formats, with self, joint, and unknown or unavailable attribution codes. The entries share the same transaction date, while their disclosure dates include January 11 and August 28, 2023. GE Aerospace designs and produces commercial and defense jet engines and related aerospace systems. In Quantellect's transaction-frequency summary, GE is tied with Dell Technologies, Pfizer, and AT&T as the most frequently disclosed securities, at two transactions apiece.

The AT&T line follows the same exchange pattern. A transaction dated April 8, 2022, and disclosed on April 21, 2022, in an official filing shows AT&T Inc. common stock exchanged for shares of Warner Bros. Discovery. The same filing includes a Becton Dickinson exchange into Embecta Corp., with a transaction date of April 1, 2022; the filing attributes both exchanges jointly. The row-level data also includes unattributed entries associated with those securities. A Dell Technologies exchange dated November 1, 2021, and disclosed December 9, 2021, lists Class C shares exchanged for VMware and attributes the transaction to a spouse. Pfizer shows a similar exchange into Viatris dated November 17, 2020, disclosed December 10, 2020, and attributed jointly in the official filing data.

Older records show the same exchange mechanism across sectors: an Ingersoll Rand transaction dated February 29, 2020, lists Ingersoll Rand Inc. as exchanged and Ingersoll Rand Plc, formerly Gardner Denver Holdings, as received; a May 23, 2019 VF Corporation transaction lists Kontoor Brands as received; and an April 8, 2019 Novartis transaction lists Alcon as received. The three sales in the record stand apart from this pattern. An April 15, 2019 full sale of Anadarko Petroleum was disclosed jointly on May 9, 2019, in a range of $15,001 to $50,000. A March 22, 2018 sale of Dr Pepper Snapple, disclosed jointly on April 1, 2018, and a September 25, 2017 sale of Abercrombie & Fitch, disclosed October 1, 2017, and attributed to Rosen herself, round out the only three transactions in the dataset coded as sales rather than exchanges.

By sector, the disclosures that carry a sector label skew toward Health Care (4 transactions), Industrials (3), and Information Technology (3), with Communication Services, Consumer Discretionary, and Utilities each accounting for 2. Eighteen of the 34 transactions, more than half, carry no sector classification in the data at all, a reminder that a meaningful share of this record cannot be sorted into a thematic bucket with the information available.

Year over year, the count of disclosed transactions has moved without a clean directional trend: 6 in 2017, 4 in 2018, 7 in 2019, 4 in 2020, 2 in 2021, 6 in 2022, and 5 in 2023. Every one of those years is composed entirely or almost entirely of the "other" category rather than purchases or sales, consistent with the exchange-driven pattern that defines the record as a whole. The most recent disclosed transaction on file is dated January 3, 2023; the earliest is dated February 1, 2017.

Quantellect does not currently publish a Quantellect Score for Senator Rosen. No score row exists for this subject as of the latest published scoring date, August 21, 2026. Among the 537 sitting members of Congress, 276 have no disclosed trades at all, and of the 100 sitting senators, 39 fall into that same zero-disclosure category. A Quantellect Score is currently published for 76 members government-wide, 73 of them sitting, which puts Rosen's record among the majority of members for whom no score is yet available.

Disclaimer

This profile is based on financial disclosures filed under the Stop Trading on Congressional Knowledge Act and related Senate ethics rules, which require members of Congress, their spouses, and dependent children to report certain transactions in stocks, bonds, and other securities. See the STOCK Act and the Senate Select Committee on Ethics financial disclosure guidance for details on reporting requirements. Disclosed transactions may reflect trades made by the member, a spouse, a dependent child, a trust, or another party, and attribution in this profile reflects only what the underlying filings specify. Amounts are reported in ranges, not exact figures, as required by law. This content is for informational purposes only and is not investment advice or a recommendation to buy or sell any security.